Plains GP Holdings LP (NYSE:PAGP) Receives $25.33 Average Price Target from Analysts

Share on StockTwits

Plains GP Holdings LP (NYSE:PAGP) has earned an average recommendation of “Buy” from the ten analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $24.25.

A number of research firms recently issued reports on PAGP. Scotiabank began coverage on Plains GP in a report on Tuesday, September 3rd. They issued an “outperform” rating and a $28.00 target price for the company. Barclays set a $24.00 target price on Plains GP and gave the company a “hold” rating in a report on Tuesday, October 15th. ValuEngine upgraded Plains GP from a “strong sell” rating to a “sell” rating in a report on Tuesday. Robert W. Baird upgraded Plains GP from a “neutral” rating to an “outperform” rating and decreased their target price for the company from $22.00 to $21.00 in a report on Monday, December 2nd. Finally, Zacks Investment Research upgraded Plains GP from a “sell” rating to a “hold” rating in a report on Friday, November 8th.

In other Plains GP news, CEO Willie Cw Chiang purchased 60,000 shares of the business’s stock in a transaction on Wednesday, November 20th. The shares were bought at an average cost of $17.14 per share, for a total transaction of $1,028,400.00. Following the completion of the purchase, the chief executive officer now directly owns 135,104 shares in the company, valued at $2,315,682.56. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Everardo Goyanes purchased 20,000 shares of the business’s stock in a transaction on Monday, November 18th. The stock was acquired at an average price of $17.91 per share, for a total transaction of $358,200.00. Following the completion of the purchase, the director now owns 57,305 shares of the company’s stock, valued at $1,026,332.55. The disclosure for this purchase can be found here. Company insiders own 16.31% of the company’s stock.

Institutional investors have recently bought and sold shares of the business. Usca Ria LLC acquired a new stake in Plains GP in the third quarter valued at $28,000. Manchester Capital Management LLC acquired a new stake in Plains GP in the second quarter valued at $38,000. Steward Partners Investment Advisory LLC acquired a new stake in Plains GP in the second quarter valued at $42,000. Cerebellum GP LLC acquired a new stake in Plains GP in the third quarter valued at $72,000. Finally, Advisor Group Inc. raised its stake in Plains GP by 107.1% in the second quarter. Advisor Group Inc. now owns 4,738 shares of the pipeline company’s stock valued at $118,000 after buying an additional 2,450 shares in the last quarter. Institutional investors own 86.41% of the company’s stock.

Shares of PAGP traded up $0.26 during midday trading on Monday, hitting $17.35. 2,174,798 shares of the stock were exchanged, compared to its average volume of 1,762,628. Plains GP has a 52-week low of $16.99 and a 52-week high of $25.82. The stock has a fifty day simple moving average of $18.50 and a 200 day simple moving average of $21.89. The firm has a market cap of $3.16 billion, a P/E ratio of 8.22 and a beta of 1.16. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 0.96.

Plains GP (NYSE:PAGP) last released its quarterly earnings results on Tuesday, November 5th. The pipeline company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.35 by $0.06. Plains GP had a return on equity of 3.30% and a net margin of 1.39%. The business had revenue of $7.89 billion during the quarter, compared to analyst estimates of $8.15 billion. During the same period last year, the business posted $0.70 earnings per share. The company’s quarterly revenue was down 10.3% on a year-over-year basis. As a group, equities research analysts forecast that Plains GP will post 2.41 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Thursday, November 14th. Investors of record on Thursday, October 31st were issued a $0.36 dividend. The ex-dividend date of this dividend was Wednesday, October 30th. This represents a $1.44 dividend on an annualized basis and a yield of 8.30%. Plains GP’s dividend payout ratio (DPR) is presently 68.25%.

Plains GP Company Profile

Plains GP Holdings, L.P. owns and operates midstream energy infrastructure in the United States and Canada. It operates through three segments: Transportation, Facilities, and Supply and Logistics. The Transportation segment engages in the transportation of crude oil and natural gas liquids (NGLs) on pipelines, gathering systems, trucks, and barges.

Recommended Story: What Does a Sell-Side Analyst Rating Mean?

Analyst Recommendations for Plains GP (NYSE:PAGP)

Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

ViaSat, Inc.  Expected to Announce Quarterly Sales of $586.23 Million
ViaSat, Inc. Expected to Announce Quarterly Sales of $586.23 Million
$231.42 Million in Sales Expected for Blackbaud, Inc.  This Quarter
$231.42 Million in Sales Expected for Blackbaud, Inc. This Quarter
MAXIMUS, Inc.  Expected to Announce Quarterly Sales of $804.28 Million
MAXIMUS, Inc. Expected to Announce Quarterly Sales of $804.28 Million
$141.84 Million in Sales Expected for AdaptHealth Corp.  This Quarter
$141.84 Million in Sales Expected for AdaptHealth Corp. This Quarter
$5.55 Billion in Sales Expected for PACCAR Inc  This Quarter
$5.55 Billion in Sales Expected for PACCAR Inc This Quarter
Advisor Partners LLC Increases Stock Holdings in Halliburton
Advisor Partners LLC Increases Stock Holdings in Halliburton


© 2006-2020 Ticker Report